Subscribe
Discussions are underway as the pharmaceutical sector calls for greater consistency in the global monitoring of GMP compliance and quality testing of APIs and finished medicines.
Falsified Medicines Directive Takes Shape in Europe
EU Sets Guidelines for Biosimilar mAbs
Report from Turkey
259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512
609-716-7777